Project Grant R01AI192415
Award Date 5/12/26
Completion Date 4/30/31
Dollars Obligated $700K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Utah $743,752 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year investigator-initiated research project beginning August 1, 2025 and concluding July 31, 2030. This Project Grant supports fundamental biomedical research investigating the epigenetic mechanisms that govern CD4+ helper T cell dysfunction during chronic viral infections....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a $3.19 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 16, 2025, with a completion date of June 30, 2029. This grant funds investigator-initiated biomedical research examining the roles and regulation of tissue-resident CD8 T cells during persistent viral infection, utilizing the lymphocytic...
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Northwestern University $627,462 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 7, 2025, for a project period extending through July 31, 2030. The research initiative focuses on understanding T cell exhaustion mechanisms in chronic viral infection through advanced molecular and cellular analysis techniques. The investigator's team will utilize paired single-cell RNA...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2.83 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Irvine for the period of July 14, 2025 through June 30, 2029. The research investigates metabolic regulation by serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS3) in virus-specific T cell immunity, with the objective of identifying novel...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $756,078 to the University of Utah on February 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research examining the mechanisms underlying divergent therapeutic responses to depleting anti-programmed death-1 (anti-PD-1) antibodies in Type 1 Diabetes (T1D). The research project, which extends through...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Utah a Project Grant of $423,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026, through March 31, 2028. This grant funds investigator-initiated biomedical research investigating the peptide specificity mechanisms of natural killer (NK) cell inhibitory receptors, specifically examining how differential bond...
- Summary of Federal Project Grant Award The National Institute of Allergy and Infectious Diseases (NIAID) awarded $159,300 to La Jolla Institute for Immunology on April 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support investigator-initiated research on human upper airway immune memory kinetics and durability against respiratory pathogens. The research project, which extends through March 31, 2031, focuses on characterizing upper airway immune cell...
- Federal Grant Award Summary New York University School of Medicine received a $466,125 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective January 29, 2026, with a completion date of December 31, 2027. The grant supports investigator-initiated biomedical research examining the role of CD69 protein in established resident memory T cells (TRM), which remain at infection...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $508,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine, with an award date of April 22, 2026, and a completion date of March 31, 2031. This research grant supports biomedical investigation into the molecular mechanisms by which innate immune cells, specifically neutrophils and professional phagocytes,...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $184,000 to the Scripps Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The research project, titled "Proximal Regulation of Innate Immune Signals in Ischemia Reperfusion Injury," focuses on establishing foundational scientific knowledge regarding how the CD14...